Auditory Biomarkers of Neuropsychiatric Disorders in Nonhuman Primates
Monica N O'Connell1,2, Annamaria Barczak3
1Translational Neuroscience Division, Center for Biomedical Imaging and Neuromodulation, Nathan Kline Institute, Orangeburg, NY, USA. noelle.oconnell@nki.rfmh.org.
Advances in Neurobiology
|November 19, 2024
Summary
Nonhuman primate (NHP) studies offer crucial insights into schizophrenia by examining auditory biomarkers. Analyzing neural oscillations in NHPs enhances the precision of translational research for developing new therapies.
Area of Science:
- Neuroscience
- Translational Research
- Psychiatry
Background:
- Animal models, particularly nonhuman primates (NHPs), are vital for understanding neuropsychiatric disorders due to genetic, physiological, and behavioral similarities with humans.
- NHP studies provide a unique opportunity to investigate the neurobiological underpinnings of cognitive and sensory deficits associated with disorders.
- Auditory biomarkers are essential for studying schizophrenia's complex symptoms and developing effective treatments.
Purpose of the Study:
- To discuss how nonhuman primate studies have illuminated auditory biomarkers in schizophrenia.
- To highlight the role of neuro-oscillatory activity in translational comparisons across species.
- To emphasize the importance of NHP models for preclinical research and therapeutic development.
Main Methods:
- Reviewing results from nonhuman primate studies on auditory biomarkers.
- Analyzing auditory steady-state responses and mismatch negativity in NHPs.
- Incorporating the analysis of local and network-level neural oscillations in auditory pathways.
Main Results:
- NHP studies have provided significant insights into the generation and modulation of auditory biomarkers relevant to schizophrenia.
- Analysis of neuro-oscillatory activity across multiple auditory processing nodes enhances translational accuracy.
- Preserved neuro-oscillatory activity across species facilitates precise cross-species comparisons.
Conclusions:
- Nonhuman primate models are instrumental in advancing our understanding of schizophrenia's neurobiology.
- The study of auditory biomarkers and neural oscillations in NHPs is key to developing targeted therapeutic interventions.
- Enhanced translational comparisons using NHP models accelerate the development of treatments for neuropsychiatric disorders.


